Refereed Journal Publications
“Bringing Value to Cancer Care Research”
with Allen et al.
2025, Frontiers in Oncology, Volume 15
“Review and Publication Times and Reporting Across Journals on Health Policy”
with Phillips KA
2025, JAMA Network Open, 8;(5):e2512545
“From Prevention to Treatment: Prescription Medication and Health Behavior”
2024, Health Economics, Volume33, Issue11, Pages 2618-2644
“Why Does the Inflation Reduction Act Exclude Expensive Cancer Treatments in Price Negotiations?”
with Abby Alpert, Mark Duggan and Mireille Jacobson
2023, Journal of Clinical Oncology – Oncology Practice, PMID: 38060993
“Biosimilar Competition and Payments in Medicare: The Case of Trastuzumab”
with Abby Alpert, Mark Duggan, Nicolas Garcia and Mireille Jacobson
2023, Journal of Clinical Oncology – Oncology Practice, no. 4, e476-e483.
“Defining Priorities in Value-Based Cancer Care: Insights from the Alliance for Clinical Trials in Oncology National Cooperative Group Survey”
with Allen et al.
2023, Journal of Clinical Oncology – Oncology Practice, Volume 19, Issue 10, 932-938
“Technology Adoption and Market Allocation: The Case of Robotic Surgery”
with Adam Sacarny and Annetta Zhou
2022, Journal of Health Economics, 86, 102672.
“Incomplete Program Take-up During a Crisis: Evidence from the COVID-19 Shock in One U.S. State”
with Marianne Bitler, Jason Cook and Nathan Seegart
2022, International Tax and Public Finance, 29, 1373–1394.
“The Effects of the Colorectal Cancer Control Program”
with Marianne Bitler and Christopher Carpenter
2021, Health Economics, Volume 30, Issue11, pp 2667-2685.
Published Book
“Chronic Resilience: 10 Sanity-Saving Tools for Women Coping with the Stress of Illness“
2013, Conari Press
Other Publications
Beyond regulation: a conversation with Dr. Robert Califf on the challenges facing healthcare and innovating community-based solutions: How can the United States harness technological innovation to transform its healthcare system to improve population health outcomes?
with Califf RA and Phillips KA
2025, Health Affairs Scholar, Volume 3, Issue 5
“Making Genetic Therapies Affordable and Accessible”
2023, Innovative Genomics Institute. [White Paper]
Working Papers
“Comparison of Food and Drug Administration Expedited Approvals and Guideline Updates: A Case Study of Colon Cancer Care” with Kevin Schulman and Kathryn Phillips [Under Review]
“Current Landscape of US Food and Drug Administration Use of Expedited Regulatory Approvals for Colorectal Cancer Care”
with Mireille Jacobson and Kathryn A. Phillips [Accepted at MCSP]
“Impact of 340B Exposure on Treatment Utilization and Cost for Medicare Patients with Cancer”
with Kevin Schulman [Under Review]
“Technology Diffusion in Health Care: Understanding the Cost and Utilization of Immunotherapy in Cancer Care”
with Abby Alpert, Mark Duggan and Mireille Jacobson
“Determinants and effects of WIC rollout: evidence from the newly digitized data from National Archives”
with Marianne Bitler, Maria Rosales-Rueda, Esra Kose, and Arian Seifoddini [Under Review]
“Effects of the Safety Net on Spending and Wellbeing: The COVID-19 Crisis Response”
with Elisa Alonso Herrero, Marianne Bitler and Arian Seifoddini [Under Review]
“Direct-to-Consumer Pharmaceutical Advertising Influence on Generic Market Entry”
“Is Medicare Spending Efficient? Connecting Expenditures to the Mortality Rate”
Master’s Thesis, 2016
Work in Progress
“Reducing disparities in cancer care: The role of supplemental insurance on the utilization of novel cancer treatments”
with Abby Alpert, Mark Duggan, and Mireille Jacobson
